Digital CBT added to usual medication for generalized anxiety
About this title
Read the official source — NCT07477990Understand this study
Who could participate?
This study is for people with anxiety. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
- Listed locations
- Mexico CitySee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 162
- Sponsor
- Psicofarma, S.A. De C.V.
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Mexico
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT07477990
- Official title
Show the full official title
Phase III, Randomized, Multicenter, Open-label Clinical Trial to Evaluate the Efficacy and Safety of the Aurora® Digital Medical Device With Conventional Drug Treatment, Compared to Conventional Drug Treatment Alone, in Adult Patients With Moderate to Severe Generalized Anxiety Disorder
Recruitment & locations
Mexico City
Questions about this study
Who is behind this study?
The study sponsor is Psicofarma, S.A. De C.V.
Does this study involve medication?
Yes. The study involves medication, including Pharmacological conventional treatment.
Who can participate?
This study is for people with anxiety. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
